Scientists now believe they can fix broken brains, not just study them. The Allen Institute in Seattle has launched a major project called the Brain Health accelerator to develop gene-based treatments for disorders like Alzheimer’s, Parkinson’s, ALS, and Huntington’s. Instead of just understanding h
Lilly has secured exclusive rights to use Ascidian’s RNA exon‑editing platform for new kidney disease treatments. The system can fix faulty genes without permanently changing a patient’s DNA, offering an alternative to traditional CRISPR methods. The deal gives Ascidian up to $1. 9 billion, split
A recent survey reached more than three thousand Swiss residents, using a random sample that balanced language groups, gender and age. The study asked people about seven different uses of somatic gene editing – changing genes in body cells for medical purposes. About one‑seventh of respondents said
A recent survey asked nearly 5, 000 adults across the United States about their thoughts on gene editing. The study focused on how people’s religious beliefs and personal experiences influence their support or worries about this technology. The sample included nine different faith traditions as w
A bright night in Los Angeles turned into a science‑theatre spectacle when the world’s leading researchers met Hollywood celebrities for the 12th Breakthrough Prize ceremony. The event, often dubbed “the Oscars of Science, ” highlighted groundbreaking work that could change lives. The Breakthroug
A Chinese tech boss is skipping traditional succession planning entirely. Instead of trusting boards or mentoring employees, he’s betting on biology. By paying American women to carry designer babies, he aims to produce an heir with pre-selected traits—like ordering custom products from a menu. This
Gene editing tools like CRISPR let us change DNA, which raises big questions about human nature. It’s no longer just about fixing diseases early—some see this as a chance to solve rare conditions before birth. But others worry we might end up picking traits for our kids, like choosing eye color or h
Cathie Wood, a well-known investor, made a significant move on the last trading day of 2025. She invested $1. 33 million in Intellia Therapeutics, a company focused on gene editing. This investment is notable because Intellia's stock has not performed well this year, dropping by 22%. Despite this, W
CRISPR is a game-changer in the world of science. It's a tool that lets researchers tweak genes with incredible precision. Right now, it's being used to create better enzymes, but we're just scratching the surface of what it can do. Enzymes are like tiny workers in our bodies. They help speed up ch
The world of gene editing is buzzing with excitement. Two companies, Crispr Therapeutics and Intellia Therapeutics, are making waves with their latest findings. Their stocks are on the rise, thanks to promising results in treating high cholesterol and a rare swelling disorder. Crispr Therapeutics s
